738
V. Barba et al. / Journal of Organometallic Chemistry 692 (2007) 731–739
dichlorodimethyltin. A red dark solid was obtained in a
yield of 78% (0.39 g). M.p. = 238–241 ꢁC. IR (KBr) m:
2919, 1616 (C@N), 1590, 1534, 1473, 1381, 1305, 1214,
1157, 743 cmꢁ1. EI MS, m/z (%): 734 ([M+1], 64), 732
C51H38N2O4Sn2: C, 62.48; H, 3.90; N, 2.85. Found: C,
61.85; H, 3.93; N, 2.72%.
4.3.2.4. Complex 2d. Compound 2d was obtained from
0.10 g (0.20 mmol) of ligand 1b and 0.12 g (0.40 mmol) of
dichlorodibutyltin. A red dark solid was obtained in a yield
of 68% (0.13 g). M.p. = 257–260 ꢁC. IR (KBr) m: 2954,
2921, 1617 (C@N), 1585, 1531, 1472, 1414, 1378, 1299,
819 cmꢁ1. EI MS, m/z (%). 970 ([M+1], 61), 968 (M+,
1
(M+, 65), 717 ([MꢁMe]+, 100), 702 ([M–2Me]+, 43). H
3
NMR (200 MHz, CDCl3) d: 8.54 (2H, s, JSn–H = 25 Hz,
H-7), 7.25 (2H, d, J = 8.2 Hz, H-5), 7.16 (2H, d,
J = 7.8 Hz, H-13), 7.09 (2H, t, J = 7.8 Hz, H-12), 6.74
(2H, d, J = 8.2 Hz, H-6), 6.67 (2H, d, J = 7.8 Hz, H-10),
6.61 (2H, t, J = 7.8 Hz, H-11), 6.95 (2H, s, H-3), 3.75
(2H, s, H-14), 0.89 (2H, s, Me) ppm. 13C NMR (50 MHz,
CDCl3) d: 168.0 (C-1), 161.8 (C-7), 159.0 (C-9), 138.0 (C-
5), 137.8 (C-3), 134.4 (C-8), 130.4 (C-4, 11), 122.9 (C-12),
118.7 (C-6), 118.0 (C-2), 116.8 (C-10), 114.9 (C-13), 39.0
(C-14), 22.3 (Me) ppm. 119Sn NMR (75 MHz, CDCl3) d:
ꢁ152 ppm. Anal. Calc. for C31H30N2O4Sn2: C, 50.86; H,
4.13; N, 3.82. Found: C, 50.76; H, 3.98; N, 3.70%.
1
65), 912 ([M–Bu]+, 100). H NMR (200 MHz, CDCl3)d:
3
8.56 (2H, s, JSn–H = 22 Hz, H-7), 7.29 (2H, dd, J = 7.4,
2.2 Hz, H-5), 7.26 (2H, d, J = 2.0 Hz, H-13), 7.12 (2H,
td, J = 8.7 Hz, 2.0 Hz, H-11), 7.04 (2H, d, J = 2.2 Hz, H-
3), 6.78 (2H, d, J = 7.4 Hz, H-6), 6.77 (2H, d, J = 8.7 Hz,
H-10), 3.84 (2H, s, H-14), 1.58-1.65 (8H, m, H-b), 1.45-
1.52 (8H, m, H-a), 1.30 (8H, sex, J = 7.2 Hz, H-c), 0.86
(12H, t, J = 7.2 Hz, H-d) ppm. 13C NMR (50 MHz,
CDCl3) d: 168.9 (C-1), 162.2 (C-7), 158.2 (C-9), 138.6 (C-
3, 5), 132.4 (C-8), 129.9 (C-11), 129.5 (C-4), 121.0 (C-12),
119.6 (C-10), 117.5 (C-2, 6), 115.1 (C-13), 39.5 (C-14),
27.4 (C-b), 26.9 (C-c), 22.4 (C-a), 13.8 (C-d) ppm. 119Sn
NMR (75 MHz, CDCl3) d: ꢁ178 ppm. Anal. Calc. for
C43H52N2O4Cl2Sn2: C, 53.28; H, 5.40; N, 2.89. Found: C,
53.62; H, 5.14; N, 2.98%.
4.3.2.2. Complex 2b. Compound 2b was obtained from
0.26 g (0.60 mmol) of ligand 1a and 0.36 g (1.20 mmol) of
dichlorodibutyltin. A red dark solid was obtained in a yield
of 59 % (0.32 g). M.p. = 242–245 ꢁC. IR (KBr) m: 2954,
2920, 2853, 1616 (C@N), 1588, 1532, 1473, 1380, 1306,
1212, 1155, 833, 741 cmꢁ1. EI MS, m/z (%): 902 ([M+1],
82), 900 (M+, 84), 843 ([MꢁBu]+, 100), 786 ([Mꢁ2Bu]+,
1
3
35). H NMR (200 MHz, CDCl3) d: 8.58 (2H, t, JSn–H
= 22 Hz, H-7), 7.29 (2H, d, J = 8.1 Hz, H-5), 7.20 (2H,
d, J = 8.0 Hz, H-13), 7.15 (2H, t, J = 8.0 Hz, H-12), 7.01
(2H, d, J = 2.2 Hz, H-3), 6.82 (2H, d, J = 8.1 Hz, H-6),
6.74 (2H, d, J = 8.0 Hz, H-10), 6.65 (2H, t, J = 8.0 Hz,
H-11), 3.81 (2H, s, H-14), 1.56–1.64 (8H, m, CH2-b),
1.40–1.50 (8H, m, CH2-a), 1.31 (8H, sex, J = 7.3 Hz,
CH2-c), 0.83 (12H, t, J = 7.3 Hz, CH2-d) ppm. 13C NMR
(50 MHz, CDCl3) d: 168.2 (C-1), 161.4 (C-7), 159.5 (C-9),
137.8 (C3, 5), 134.3 (C-8), 130.4 (C-4, C-11), 122.8 (C-
12), 118.6 (C-6), 117.6 (C-2), 116.4 (C-10) 114.8 (C-13),
39.7 (C-14), 27.4 (C-b), 27.0 (C-c), 22.4 (C-a), 14.0 (C-d)
ppm. 119Sn NMR (75 MHz, CDCl3)d: ꢁ192 ppm. Anal.
Calc. for C43H54N2O4Sn2: C, 57.36; H, 6.04; N, 3.11.
Found: C, 56.96; H, 5.88; N, 3.20%.
4.3.2.5. Complex 2e. Compound 2e was obtained from
0.10 g (0.20 mmol) of ligand 1b and 0.14 g (0.40 mmol) of
dichlorodiphenyltin. An orange solid was obtained with
yield of 48% (0.10 g). M.p. = 295–298 ꢁC. IR (KBr) m:
2946, 1617 (C@N), 1590, 1534, 1473, 1377, 1296, 825,
732 cmꢁ1. FAB MS, m/z (%): 1050 ([M+1], 54), 1048
(M+, 60), 974 ([MꢁPh]+, 100). 1H NMR (200 MHz,
3
CDCl3) d: 8.51 (2H, s, JSn–H = 27 Hz, H-7), 7.82–7.92
(8H, m, H-o), 7.32–7.42 (12H, m, H-m, p), 6.96–7.30
(12H, m, H-3, 5, 6, 10, 11, 13), 3.81 (2H, s, H-14) ppm.
13C NMR (50 MHz, CDCl3) d: 168.4 (C-1), 161.8 (C-7),
157.4 (C-9), 139.4 (C-5), 138.6 (C-3, C-i), 136.5 (C-o),
131.7 (C-8), 130.5 (C-11), 129.9 (C-p), 129.8 (C-4), 128.7
(C-m) 121.5 (C-12), 119.9 (C-10), 117.5 (C-2, 6), 114.9
(C-13), 39.6 (C-14) ppm. 119Sn NMR (75 MHz, CDCl3)
d: ꢁ329 ppm. Anal. Calc. for C51H36N2O4Cl2Sn2: C,
58.38; H, 3.45; N, 2.67. Found: C, 57.99; H, 3.43; N, 2.73%.
4.3.2.3. Complex 2c. Compound 2c was obtained from
0.19 g (0.436 mmol) of ligand 1a and 0.30 g (0.87 mmol)
of dichlorodiphenyltin. An orange solid was obtained in
a yield of 91% (0.39 g). M.p. = 285–287 ꢁC. IR (KBr) m:
3050, 1615 (C@N), 1590, 1535, 1473, 1379, 1305, 1157,
835, 735 cmꢁ1. FAB MS, m/z (%): 982 ([M+2, 70), 980
(M+, 75), 903 ([MꢁPh]+, 100). 1H NMR (200 MHz,
4.3.2.6. Complex 2f. Compound 2f was obtained from
0.10 g (0.18 mmol) of ligand 1c and 0.11 g (0.36 mmol) of
dichlorodibutyltin. A red dark solid was obtained in a yield
of 80 % (0.16 g). Mp = 288–291 ꢁC. IR (KBr) m: 2923,
2861, 1616 (C@N), 1589, 1532, 1492, 1465, 1375, 1279,
1168, 827 cmꢁ1. FAB MS, m/z (%): 1014 ([M+1], 92),
3
CDCl3)d: 8.60 (2H, s, JSn–H, = 29 Hz, H-7), 7.84 (8H,
1
dd, J = 7.3,1.8 Hz, H-o), 6.90–7.20 (18H, m, H-3, 5, 6,
10, 12, 13, m, p), 6.66 (2H, td, J = 8.4, 2.2 Hz, H-11),
3.82 (2H, s, H-14) ppm. 13C NMR (50 MHz, CDCl3)d:
168.2 (C-1), 161.2 (C-7), 156.5 (C-9), 139.7 (C-5, C-i),
138.1 (C-3), 136.5 (C-o), 134.5 (C-8), 130.3 (C-11, C-p),
128.7 (C-m), 128.1 (C-4), 123.1(C-12), 119.0 (C-6), 117.3
(C-2), 116.9 (C-10), 114.7 (C-13), 39.7 (C-14) ppm. 119Sn
NMR (75 MHz, CDCl3) d: ꢁ333 ppm. Anal. Calc for
1012 (M+, 98), 956 ([MꢁBu]+, 100). H NMR (200 MHz,
3
CDCl3) d: 8.59 (2H, s, JSn–H = 24 Hz, H-7), 7.15–7.25
(6H, m, H-5, H-11, H-13), 7.08 (2H, s, H-3), 6.78 (2H, d,
J = 8.4 Hz, H-6), 6.74 (2H, d, J = 8.4 Hz, H-10), 3.83
(2H, s, H-14), 1.60–1.70 (8H, m, H-b), 1.40–1.50 (8H, m,
H-a),1.32 (18H, m, t-Bu), 1.27 (8H, sex, J = 7.4 Hz, H-c),
0.83 (12H, t, J = 7.4 Hz, H-d) ppm. 13C NMR (50 MHz,
CDCl3) d: 167.9 (C-1), 160.8 (C-7), 157.1 (C-9), 139.7 (C-